-
MNC interim report scan | K-drug generates over $14.2 billion in revenue, HPV growth is weak, Merck urgently needs the next 'internet celebrity' successor
On July 30th, Merck announced its first half of 2024 results, with a total revenue of 31.887 billion US dollars, a year-on-year increase of 8%. Merck's pharmaceutical business revenue was 28.415 bill ... -
MNC interim report scan | Simeglutide's sales in the first half of the year were nearly 13 billion US dollars. Can Novo Nordisk create a new "drug king"?
Nowadays, "Simei", GLP-1, and weight loss have become hot topics among the public, and Novo Nordisk has seized the opportunity to deliver impressive performance in the weight loss sector in the first ... -
NIO falls more than 6% in mid year report, refutes rumors of bankruptcy and reports to the police
Affected by recent market rumors, NIO SW (09866. HK) continues to weaken. As of press time, it fell 6.25% to HKD 31.5. Note: NIO's trend In terms of news, NIO's legal department announced on its offi ...